MedPharm Moves Toward Federal Approval
An interview with Albert Gutierrez, CEO of MedPharm, discussing recent movements by the DEA to move forward with medical cannabis research.
By now, it’s not news that the cannabis industry operates without any national or global regulatory oversight. The lack of industry-wide standards or protocols has led to the development of a patchy network of similar, yet unperfected, regulated markets. It's an unstable framework which has led to a frustrating and repeating pattern of scandals, many of which are entirely avoidable.
With the popularity of indoor cultivation, grow environments are becoming easier than ever to regulate. Learn what data needs to be collected to ensure production of the same high-quality crop over multiple harvests.
Colorado State University-Pueblo, Institute of Cannabis Research hosted their annual academic conference regarding advances in cannabis science and technology. Cannabis Tech’s Kristina Etter attended the Sunday session for a first-hand perspective of cannabis advances from the researchers themselves.